ETRUSVYQUE Trademark

Trademark Overview


On Tuesday, August 9, 2022, a trademark application was filed for ETRUSVYQUE with the United States Patent and Trademark Office. The USPTO has given the ETRUSVYQUE trademark a serial number of 97541170. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2024. This trademark is owned by Glaxo Group Limited. The ETRUSVYQUE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
etrusvyque

General Information


Serial Number97541170
Word MarkETRUSVYQUE
Filing DateTuesday, August 9, 2022
Status700 - REGISTERED
Status DateTuesday, July 9, 2024
Registration Number7436209
Registration DateTuesday, July 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Friday, May 26, 2023ASSIGNED TO EXAMINER
Friday, August 12, 2022NEW APPLICATION ENTERED
Monday, August 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 30, 2023SUSPENSION LETTER WRITTEN
Tuesday, May 30, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, May 30, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 25, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 10, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, March 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 18, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, March 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED